Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2019 3
2020 2
2021 7
2022 11
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Small Molecule Drugs in Inflammatory Bowel Diseases.
Ben Ghezala I, Charkaoui M, Michiels C, Bardou M, Luu M. Ben Ghezala I, et al. Pharmaceuticals (Basel). 2021 Jun 30;14(7):637. doi: 10.3390/ph14070637. Pharmaceuticals (Basel). 2021. PMID: 34209234 Free PMC article. Review.
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
Launay O, Cachanado M, Luong Nguyen LB, Ninove L, Lachâtre M, Ben Ghezala I, Bardou M, Schmidt-Mutter C, Lacombe K, Laine F, Allain JS, Botelho-Nevers E, Tavolacci MP, Chidiac C, Pavese P, Dussol B, Priet S, Deplanque D, Touati A, Curci L, Konate E, Ben Hamouda N, Besbes A, Nubret E, Capelle F, Berard L, Rousseau A, Tartour E, Simon T, de Lamballerie X. Launay O, et al. Among authors: ben ghezala i. N Engl J Med. 2022 Jul 28;387(4):374-376. doi: 10.1056/NEJMc2206711. Epub 2022 Jun 29. N Engl J Med. 2022. PMID: 35767474 Free PMC article. No abstract available.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
de Bruyn G, Wang J, Purvis A, Ruiz MS, Adhikarla H, Alvi S, Bonaparte MI, Brune D, Bueso A, Canter RM, Ceregido MA, Deshmukh S, Diemert D, Finn A, Forrat R, Fu B, Gallais J, Griffin P, Grillet MH, Haney O, Henderson JA, Koutsoukos M, Launay O, Torres FM, Masotti R, Michael NL, Park J, Rivera-Medina DM, Romanyak N, Rook C, Schuerman L, Sher LD, Tavares-Da-Silva F, Whittington A, Chicz RM, Gurunathan S, Savarino S, Sridhar S; VAT00002 booster cohorts study team. de Bruyn G, et al. EClinicalMedicine. 2023 Jul 22;62:102109. doi: 10.1016/j.eclinm.2023.102109. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37533419 Free PMC article.
Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors.
Thibault T, Ben Ghezala I, Freppel R, Rajillah A, Boulay C, Brunel P, Atzenhoffer M, Auvens C, Devilliers H, Grandvuillemin A. Thibault T, et al. Among authors: ben ghezala i. Ophthalmology. 2024 Feb;131(2):249-251. doi: 10.1016/j.ophtha.2023.10.004. Epub 2023 Oct 10. Ophthalmology. 2024. PMID: 37820932 No abstract available.
24 results